Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-κB signaling pathway
- PMID: 24401903
- DOI: 10.3892/mmr.2014.1888
Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-κB signaling pathway
Abstract
Ion channels have been suggested to be important in the development and progression of tumors, however, chloride channels have rarely been analyzed in tumorigenesis. More recently, transmembrane protein with unknown function 16A (TMEM16A), hypothesized to be a candidate calcium‑activated Cl‑ channel, has been found to be overexpressed in a number of tumor types. Although several studies have implicated the overexpression of TMEM16A in certain tumor types, the exact role of TMEM16A in gliomas and the underlying mechanisms in tumorigenesis, remain poorly understood. In the present study, the role of TMEM16A in gliomas and the potential underlying mechanisms were analyzed. TMEM16A was highly abundant in various grades of gliomas and cultured glioma cells. Knockdown of TMEM16A suppressed cell proliferation, migration and invasion. Furthermore, nuclear factor‑κB (NF‑κB) was activated by overexpression of TMEM16A. In addition, TMEM16A regulated the expression of NF‑κB‑mediated genes, including cyclin D1, cyclin E and c‑myc, involved in cell proliferation, and matrix metalloproteinases (MMPs)‑2 and MMP‑9, which are associated with the migration and invasion of glioma cells. Collectively, results of the present study provide evidence for the involvement of TMEM16A in gliomas and the potential mechanism through which TMEM16A promotes glioma formation.
Similar articles
-
TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.Oncotarget. 2015 May 10;6(13):11585-99. doi: 10.18632/oncotarget.3412. Oncotarget. 2015. PMID: 25839162 Free PMC article.
-
Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway.J Pathol. 2012 Feb;226(3):534-43. doi: 10.1002/path.3008. Epub 2011 Dec 5. J Pathol. 2012. PMID: 21960069
-
Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells.PLoS One. 2014 Dec 26;9(12):e115443. doi: 10.1371/journal.pone.0115443. eCollection 2014. PLoS One. 2014. PMID: 25541940 Free PMC article.
-
Role of Cl- channels in primary brain tumour.Cell Calcium. 2019 Jul;81:1-11. doi: 10.1016/j.ceca.2019.05.004. Epub 2019 May 14. Cell Calcium. 2019. PMID: 31129471 Review.
-
Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in cancer.Mol Cancer. 2017 Sep 11;16(1):152. doi: 10.1186/s12943-017-0720-x. Mol Cancer. 2017. PMID: 28893247 Free PMC article. Review.
Cited by
-
ANO1: More Than Just Calcium-Activated Chloride Channel in Cancer.Front Oncol. 2022 Jun 6;12:922838. doi: 10.3389/fonc.2022.922838. eCollection 2022. Front Oncol. 2022. PMID: 35734591 Free PMC article.
-
Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression.Cells. 2020 Apr 26;9(5):1079. doi: 10.3390/cells9051079. Cells. 2020. PMID: 32357567 Free PMC article.
-
Diethylstilbestrol, a Novel ANO1 Inhibitor, Exerts an Anticancer Effect on Non-Small Cell Lung Cancer via Inhibition of ANO1.Int J Mol Sci. 2021 Jul 1;22(13):7100. doi: 10.3390/ijms22137100. Int J Mol Sci. 2021. PMID: 34281152 Free PMC article.
-
The roles and functions of TMEM protein family members in cancers, cardiovascular and kidney diseases (Review).Biomed Rep. 2025 Feb 11;22(4):63. doi: 10.3892/br.2025.1941. eCollection 2025 Apr. Biomed Rep. 2025. PMID: 39991002 Free PMC article. Review.
-
ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.Oncotarget. 2015 Apr 20;6(11):9173-88. doi: 10.18632/oncotarget.3277. Oncotarget. 2015. PMID: 25823819 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous